FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Untitled Letter Sent to Fidia Pharma

CBER issues an untitled letter to Fidia Pharma USA after reviewing the companys Web sites and determining that its cell/tissue products require a BLA ...

latest-news-card-1
Federal Register

Guide on Clinical Outcome Assessments

Federal Register notice: FDA makes available a draft guidance on incorporating clinical outcome assessments into endpoints.

latest-news-card-1
Federal Register

Guide on Drug Mfg. Discontinuance/Interruptions

Federal Register notice: FDA makes available a draft guidance entitled Notification of a Permanent Discontinuance or Interruption in Manufacturing Und...

latest-news-card-1
Human Drugs

FDA Pulls Makena Approval Immediately

FDA commissioner Robert Califf and chief scientist Namandj Bumpus withdraw Covis Pharmas preterm birth drug Makena and its generics from the market ef...

latest-news-card-1
Medical Devices

FDA Clears restor3D 510(k) for Ankle Device

FDA clears a restor3d 510(k) for the Axiom PSR System for use with the companys Kinos Axiom Total Ankle System.

latest-news-card-1
Human Drugs

2 Texas Men Plead Guilty to Misbranded Drug Sales

The Justice Department says two Texas men face up to five years in prison after pleading guilty to selling misbranded drugs over the Internet.

latest-news-card-1
Federal Register

NADA Human Safety Assessment Guide

Federal Register notice: FDA announces the availability of a draft guidance entitled Human User Safety (HUS) in New and Abbreviated New Animal Drug Ap...

latest-news-card-1
Human Drugs

Endpoint Clinical Outcome Assessment Guidance

FDA publishes the last in a series of four guidances on aspects of patient-focused drug development.

latest-news-card-1
Medical Devices

3 Ex-Magellan Officials Charged Over Device Malfunctions

The Justice Department charges three former top officials at Magellan Diagnostics over their role in allegedly concealing a device malfunction that pr...

latest-news-card-1
Human Drugs

Multiple Violations in Aspire Pharma Inspection

FDA warns Somerset, NJ-based Aspire Pharmaceuticals about multiple violations in its production of dietary supplements and human drugs.